Allopurinol treatment and its effect on renal function in gout: a controlled study

Area of Science:

• Nephrology
• Rheumatology
• Pharmacology

Background:

• Gout is characterized by hyperuricemia, which may negatively impact renal function.
• Colchicine is a common treatment for gout flares, but its long-term effects on kidney function are not fully understood.
• Allopurinol reduces uric acid production and is a cornerstone of chronic gout management.

Purpose of the Study:

• To evaluate the long-term effects of colchicine alone versus a combination of colchicine and allopurinol on renal function in patients with primary gout.
• To investigate the impact of allopurinol on specific markers of renal function and urate metabolism.

Main Methods:

• A prospective study involving 59 patients with primary gout.
• Patients were randomized to receive either colchicine alone or a combination of colchicine and allopurinol.
• Renal function, including glomerular filtration rate and urine concentrating ability, was assessed over a 2-year period.

Main Results:

• Patients treated with colchicine alone showed a statistically significant decline in glomerular filtration rate and urine concentrating ability.
• Renal function remained stable in patients receiving allopurinol.
• Allopurinol treatment led to reduced ammonium excretion and a decline in urate clearance, highlighting its uricosuric effects.
• Allopurinol appeared to retard the decline in renal function, likely due to its hypouricemic effect.

Conclusions:

• Allopurinol demonstrates a renoprotective effect in patients with gout, preserving renal function over a 2-year period.
• The hyperuricemia associated with gout is detrimental to kidney health.
• Combination therapy with allopurinol is superior to colchicine alone for maintaining renal function in gout patients.